¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Wiskott-Aldrich Syndrome Protein, Neuronal"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • complex regional pain syndrome
    º¹ÇÕºÎÀ§ÅëÁõÁõÈıº
  • compression syndrome
    ¾Ð¹ÚÁõÈıº
  • congenital rubella syndrome
    ¼±ÃµÇ³ÁøÁõÈıº
  • Conn¡¯s syndrome
    ÄÜÁõÈıº
  • carcinoid syndrome
    Ä«¸£½Ã³ëÀ̵åÁõÈıº
  • CREST syndrome
    Å©·¹½ºÆ®ÁõÈıº
  • cri du chat syndrome
    °í¾çÀÌ¿ïÀ½ÁõÈıº
  • Crigler-Najjar syndrome
    Å©¸®±Û·¯-³ªÀÚ¸£ÁõÈıº
  • Cronkhite-Canada syndrome
    Å©·ÐÅ©ÇÏÀÌÆ®-ij³ª´ÙÁõÈıº
  • Crouzon¡¯s syndrome
    Å©·çÁ¾ÁõÈıº
  • crush syndrome
    À¸±þÁõÈıº, ¾Ð±ËÁõÈıº
  • cubital tunnel syndrome
    ÆÈ²ß±¼ÁõÈıº, ÁÖ°üÀýÅͳÎÁõÈıº
  • culture-bound syndrome
    ¹®È­±ÇÁõÈıº
  • Cushing¡¯s syndrome
    Äí½ÌÁõÈıº
  • carotid sinus syndrome
    ¸ñµ¿¸Æ±¼ÁõÈıº, °æµ¿¸Æµ¿ÁõÈıº
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • chronic fatigue syndrome
    ¸¸¼ºÇÇ·ÎÁõÈıº
  • chronic pain syndrome
    ¸¸¼ºÅëÁõÁõÈıº
  • clinical syndrome
    ÀÓ»óÁõÈıº
  • clumsy child syndrome
    µÐÇѾƵ¿ÁõÈıº
  • clumsy hand syndrome
    ¼­Å÷¼ÕÁõÈıº
  • co-contraction syndrome
    µ¿½Ã¼öÃàÁõÈıº
  • combined immunodeficiency syndrome
    º¹Çո鿪°áÇÌÁõÈıº
  • compartment syndrome
    ±¸È¹ÁõÈıº
  • complex regional pain syndrome
    º¹ÇÕ±¹¼Òµ¿ÅëÁõÈıº
  • compression syndrome
    ¾Ð¹ÚÁõÈıº
  • concentration camp syndrome
    ¼ö¿ë¼ÒÁõÈıº
  • congenital constriction ring syndrome
    ¼±ÃµÇùÂø°í¸®ÁõÈıº
  • cor pulmonale syndrome
    Æó½ÉÀåÁõÈıº, ÇãÆÄ½ÉÀåÁõÈıº
  • cord compression syndrome
    ô¼ö¾Ð¹ÚÁõÈıº
  • cranial nerve syndrome
    ³ú½Å°æÁõÈıº
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • Behcets syndrome
    º£Ã¼Æ® ÁõÈıº
  • Benedikts syndrome
    º£³×µñÆ®ÁõÈıº
  • Blackfan-Diamond syndrome
    ºí·¢ÆÇ-´ÙÀ̾ƸóµåÁõÈıº
  • Bloom syndrome
    ºí·ç¿òÁõÈıº(¡­ñøý¦ÏØ).
  • Briquets syndrome
    ºê¸®ÄÉ ÁõÈıº
  • CREST syndrome
    Å©·¹½ºÆ® ÁõÈıº
  • CRST(Calcinosis, Raynauds phenomenon, Sclerodactyly, Telangiectasia) syndrome
    CRST ÁõÈıº.
  • Cestans syndrome
    ¼¼½ºÅºÁõÈıº.
  • Chandlers syndrome
    îµé·¯ÁõÈıº
  • Charcot-Wilbrand syndrome
    »þ¸£ÄÚ-ºôºê¶õµåÁõÈıº.
  • Charcots syndrome
    »þ¸£ÄÚÁõÈıº.
  • Charlins syndrome
    »þ¸¦·©ÁõÈıº.
  • Chauffard-Still syndrome
    ¼îÆÄ¸£-½ºÆ¿ÁõÈıº.
  • Chediak-Higashi syndrome
    ¼¼µð¾ÆÅ©-È÷°¡½Ã ÁõÈıº
  • Chediak-Higashi syndrome
    ¼¼µð¾ÆÅ©-È÷°¡½ÃÁõÈıº.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • protein
    ´Ü¹é(Ó±ÛÜ), ´Ü¹éÁú(Ó±ÛÜòõ)
  • protein
    ´Ü¹é(Áú)
  • protein 3
    ´Ü¹é 3
  • protein 4.1
    ´Ü¹é 4.1
  • protein A
    ´Ü¹éÁú A (Æ÷µµ±¸±ÕÀÇ)
  • protein C
    C ´Ü¹é
  • protein S
    S ´Ü¹é
  • protein binding
    (Ç÷Àå)´Ü¹é°áÇÕ.
  • protein binding
    ´Ü¹éÁú °áÇÕ
  • protein bound iodine
    ´Ü¹éÁú°áÇÕ¿ä¿Àµå
  • protein bound iodine =PBI
    ´Ü¹éÁú°áÇÕ¿ä¿Àµå.
  • protein c
    ´Ü¹é C
  • protein calorie malnutrition
    ´Ü¹é¿­·®¿µ¾ç ½ÇÁ¶.
  • protein calorie malnutrition
    ´Ü¹é¿­·®¿µ¾ç ½ÇÁ¶(Ó±ÛÜæðÕáç½å× ã÷ðà)
  • protein decomposition
    ´Ü¹éºÐÇØ(Ó±ÛÜÝÂú°).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
  • isoelectric protein
    µîÀü´Ü¹éÁú(Ôõï³Ó±ÛÜòõ)
  • isoionic protein
    µî(Ôõ)À̿ ´Ü¹éÁú(Ó±ÛÜòõ)
  • late protein
    ¸¸±â´Ü¹éÁú(عѢӱÛÜòõ)
  • leader protein
    ¼±µµ´Ü¹éÁú(à»ÓôÓ±ÛÜòõ)
  • leaky protein
    ´©Ãâ´Ü¹éÁú(שõóÓ±ÛÜòõ)
  • LETS protein
    LETS ´Ü¹éÁú(Ó±ÛÜòõ)
  • light-harvesting Chl a/b protein
    Áý±¤¼º¿±·Ïü(ó¢ÎÃàõç¨Öàô÷) a/b ´Ü¹éÁú(Ó±ÛÜòõ)
  • link protein
    ¿¬°á´Ü¹éÁú(֧̿ӱÛÜòõ)
  • lipid-globular protein mosaic model
    "ÁöÁú-±¸»ó´Ü¹éÁú(ò·òõϹßÒÓ±ÛÜòõ) , ¸ðÀÚÀÌÅ©¸ðµ¨"
  • liquid protein diet
    ¾×ü´Ü¹éÁú½Ä(äûô÷Ó±ÛÜòõãÝ)
  • low-potential iron protein
    ÀúÀüÀ§ ö´Ü¹éÁú(î¸ï³êÈôÑÓ±ÛÜòõ)
  • low-quality protein
    ÀúÁú´Ü¹éÁú(î¸òõÓ±ÛÜòõ)
  • matrix protein
    ±âÁú´Ü¹éÁú(ѨòõÓ±ÛÜòõ)
  • maturation protein
    ¼º¼÷´Ü¹éÁú(à÷âÙÓ±ÛÜòõ)
  • melting protein
    À¶ÇشܹéÁú(ë×ú°Ó±ÛÜòõ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
EDS edema disease of swine; egg drop syndrome; Ehlers-Danlos syndrome; Emery-Dreifus syndrome; energy-di...
FS factor of safety; Fanconi syndrome; Felty syndrome; fibromyalgia syndrome; field stimulation; Fisher...
GS gallstone; Gardner syndrome; gastric shield; general surgery; gestational score; Gilbert syndrome; g...
HSS Hallermann-Streiff syndrome; Hallervorden-Spatz syndrome; Henoch-Schonlein syndrome; high-speed supe...
MAS magic angle spinning; Manifest Anxiety Scale; maximum average score; McCune-Albright syndrome; mecon...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 8
ARN Acute retinal necrosis syndrome
ATLS Acute tumor lysis syndrome
AGS Adrenogenital Syndrome
AGS Alagille syndrome
AWS Alcohol Withdrawal Syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • burning feel syndrome
    ÀÛ¿­°¨ ÁõÈıº, ¼ÒÀÛÁ· ÁõÈıº
  • Bäfverstedt's syndrome
    º£Æä¸£½ºÅׯ® ÁõÈıº
  • capillary leak syndrome
    ¸ð¼¼Ç÷°ü ´©Ãâ ÁõÈıº
  • caplans syndrome
    ijÀÌÇöõ ÁõÈıº
  • carcinoid syndrome
    Ä«¸£½Ã³ëÀ̵å ÁõÈıº
  • cardiofaciocutaneous syndrome
    ½ÉÀå-¾ó±¼-ÇǺΠÁõÈıº
  • carotid artery syndrome
    °æµ¿¸Æ ÁõÈıº
  • carotid sinus syndrome
    °æµ¿¸Æµ¿ ÁõÈıº
  • carpal tunnel syndrome
    ¼ö±Ù°ü ÁõÈıº, ÆÈ¸ñ ÅͳΠÁõÈıº
    1. ¼Õ°¡¶ôÀ» Á¶ÀýÇÏ´Â Àδ븦 µÑ·¯½Î´Â Ȱ¸·ÀÌ ÀÚ±ØÀ» ¹Þ°Å³ª ¿°ÁõÀÌ »ý±ä °Í. ÆÈ¸ñ ÅͳΠÁõÈıºÀº ¼ÕÀ¸·Î ÀÛ¾÷À» ÇÏ´Â »ç¶÷µé ƯÈ÷ °Ç¹Ý ¾Ç±â¸¦ ¿¬ÁÖ°¡, ŸÀÚ¼ö ±×¸®°í ÀÚ·á °ü¸®ÀÚ µî°ú °°Àº »ç¶÷¿¡°Ô Àå¾Ö°¡ ¹ß»ýÇÑ´Ù. 2. ¼ö±Ù°ü³» Á¤Áß ½Å°æÀÌ ¾Ð¹ÚµÉ ¶§ ÀϾ´Â ÁõÈıºÀ¸·Î¼­, ¼Õ°¡¶ôÀÇ µ¿Åë, ÀÛ¿­°¨ ±×¸®°í ÀÌ»ó °¨°¢À» µ¿¹ÝÇϸç, ¶§·Î´Â ÆÈ²ÞÄ¡±îÁö ÆÄ±ÞµÈ´Ù. 3. ¼ö±Ù°üÀº ¼Õ¸ñÀÇ ¼öÀåºÎ¿¡ À§Ä¡Çϸç, ¹èÃø°ú Ãøº®Àº ¼ö±Ù°ñ·Î ±¸¼ºµÇ°í, º¹ÃøÀº ´Ü´ÜÇÑ ¼¶À¯¼º Ⱦ¼ö±Ù Àδë·Î µ¤Çô ÅͳÎÀ» Çü¼ºÇÑ´Ù. Åͳγ»¿¡´Â Á¤Áß ½Å°æ, õÁö±¼±Ù, ½ÉÁö±¼±Ù, À幫Áö±¼±ÙÀÌ Åë°úÇϴµ¥ Á¤Áß ½Å°æÀÇ ¾Ð¹ÚÀ¸·Î ¹ß»ýÇÏ´Â ÁõÈıºÀÌ´Ù.
  • Carpenter syndrome
    Ä«¾ÆÆæÅÍ ÁõÈıº
    ÷µÎ, ´ÙÁö ÇÕÁöÁõ, ´ÜÁöÁõ, ÀÌ»ó ¾È¸é, ºñ¸¸Áõ, Áö´ÉÀúÇÏ, ¼º¼± ±â´É ºÎÀüÀ» µ¿¹ÝÇÏ´Â »ó¿°»öü ¿­¼º À¯Àü¼º ÁõÈıº.
  • cartoid sinus syndrome
    °æµ¿¸Æµ¿ ÁõÈıº
  • catcry syndrome
    ¹¦¼º ÁõÈıº
  • cauda equina syndrome
    ¸¶¹Ì ÁõÈıº
  • cell-mediated immunodeficiency syndrome
    ¼¼Æ÷¼º ¸é¿ª °áÇÌ ÁõÈıº
  • cerebrohepatorenal syndrome
    ³ú°£ ½Å ÁõÈıº
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 8
Vps15 protein kinase <enzyme> Functions with vps34p as a membrane-associated complex which facilitates the delivery of proteins into the vacuole in yeast; amino acid sequence has been determined
Registry number: EC 2.7.10.-
Synonym: vps15 gene product, vps15p
(26 Jun 1999)
retinoblastoma protein <molecular biology, protein> Product of the retinoblastoma tumour suppressor gene.
It is a nuclear phosphoprotein hypothesised to normally act as an inhibitor of cell proliferation. Rb protein is absent in retinoblastoma cell lines. It also has been shown to form complexes with the adenovirus e1a protein, the sv40 t antigen, and the human papilloma virus e7 protein.
(03 Jul 1999)
retinol-binding protein <molecular biology> Proteins which bind with retinol.
The retinol-binding protein found in plasma has an alpha-1 mobility on electrophoresis and a molecular weight of 21,000-22,000. The protein has one binding site for retinol and is responsible for the transport of vitamin A.
The retinol- protein complex (molecular weight 80,000 to 90,000) circulates in plasma in the form of a protein-protein complex with prealbumin. The retinol-binding protein found in tissue has a molecular weight of 14,000 and carries retinol as a non-covalently-bound ligand.
(03 Jul 1999)
PEP protein tyrosine phosphatase <enzyme> Pest - pro, glu, ser and thr; an intracellular ptpase expressed primarily by cells of haematopoietic origin; involved in regulating nuclear tyrosine phosphorylation; amino acid sequence has been determined
Registry number: EC 3.1.3.-
Synonym: pep ptpase, pest-enriched phosphatase, ptp-pest
(26 Jun 1999)
membrane protein <protein> A protein with regions permanently attached to a membrane (peripheral membrane protein) or inserted into a membrane integral membrane protein). Insertion into a membrane implies hydrophobic domains in the protein. All transport proteins are integral membrane proteins.
(18 Nov 1997)
channel protein <chemistry, physiology> A protein that facilitates the diffusion of molecules/ions across lipid membranes by forming a hydrophilic pore. most frequently multimeric with the pore formed by subunit interactions.
(18 Nov 1997)
G-protein <cell biology, molecular biology> Intracellular membrane-associated proteins activated by several (e.g., beta adrenergic) receptors.
They serve as second messengers or transducers of the receptor-initiated response to intracellular elements such as enzymes to initiate an effect. They are also mediators of activated cell-surface receptors and their enzymes or of ion channels.
They are responsible for activating a chain of events that alters the concentration of intracellular signaling molecules such as cyclic AMP and calcium. In turn, these intracellular messengers alter the behaviour of other target proteins within the cell.
These proteins have a high affinity for guanine nucleotides and hence are named "G" proteins.
Synonym: G-protein, GTP-binding proteins.
(12 Jul 2000)
G-protein coupled receptor <cell biology> Cell surface receptors that are coupled to G-proteins (GTP-binding protein).
G-protein coupled receptors are thought to have seven membrane spanning domains and have been divided into 2 subclasses: those in which the binding site is in the extracellular domain for example receptors for glycoprotein hormones, such as thyroid stimulating hormone (TSH) and follicle-stimulating hormone (FSH) and those in which the ligand binding site is likely to be in the plane of the 7 transmembrane domains for example rhodopsin and receptors for small neurotransmitters and hormones for example muscarinic acetylcholine receptor.
(18 Nov 1997)
G-protein, inhibitory GI A g-protein that inhibits adenylyl cyclase and activates k+ channels.
(12 Dec 1998)
G-protein, stimulatory gs A G-protein that mediates the receptor activation of adenylyl cyclase.
(12 Dec 1998)
chemotactic protein methylesterase <enzyme> Demethylates methyl-accepting chemotaxis proteins
Registry number: EC 3.1.1.-
Synonym: chemotactic methylesterase, carboxymethylesterase of chemotaxis, cheb methylesterase
(26 Jun 1999)
peripheral membrane protein <protein> Membrane proteins that are bound to the surface of the membrane and not integrated into the hydrophobic region. Usually soluble and were originally thought to bind to integral proteins by ionic and other weak forces (and could therefore be removed by high ionic strength, for example). However, it is now clear that some peripheral membrane proteins are covalently linked to molecules that are part of the membrane bilayer (see acylated proteins and glypiation) and that there are others that fit the original definition but are perhps more appropriately considered proteins of the cytoskeleton (e.g. Band 4.1 and spectrin) or extracellular matrix (e.g. Fibronectin).
(18 Nov 1997)
peripheral protein <protein> A water-soluble protein that is loosely bound (by hydrogen bonds orelectrostatic forces) to a membrane.
(09 Oct 1997)
periplasmic protein disulfide oxidoreductase <enzyme> Isolated from haemophilus influenzae; may be required for assembly or folding of one or more disulfide-containing cell envelope proteins; ccmg isolated from paracoccus denitrificans
Registry number: EC 1.8.4.-
Synonym: por disulfide oxidoreductase, por gene product, periplasmic oxidoreductase, ccmg gene product
(26 Jun 1999)
ribose binding protein <protein> Periplasmic binding proteins of bacteria that interact either with the ribose transport system or with the methyl accepting chemotaxis protein MCP III (trg).
(18 Nov 1997)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 8
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 8
ÅëÇÕ°Ë»ö ¿Ï·á